{"id":229171,"date":"2026-03-30T08:24:00","date_gmt":"2026-03-30T12:24:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/03\/30\/eli-lilly-makes-2-75-billion-bet-on-ai-powered-drug-discovery\/"},"modified":"2026-03-30T08:40:15","modified_gmt":"2026-03-30T12:40:15","slug":"eli-lilly-makes-2-75-billion-bet-on-ai-powered-drug-discovery","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/03\/30\/eli-lilly-makes-2-75-billion-bet-on-ai-powered-drug-discovery\/","title":{"rendered":"Eli Lilly Makes $2.75 Billion Bet on AI-Powered Drug Discovery"},"content":{"rendered":"

Eli Lilly Makes $2.75 Billion Bet on AI-Powered Drug Discovery<\/a><\/p>\n

https:\/\/www.pymnts.com\/artificial-intelligence-2\/2026\/eli-lilly-makes-2-75-billion-bet-on-ai-powered-drug-discovery\/<\/a><\/p>\n

Publish Date: 2026-03-30 08:24:00<\/a><\/p>\n

Source Domain: www.pymnts.com<\/a><\/p>\n

Pharmaceutical titan\u00a0Eli Lilly\u00a0wants to bring medications developed with AI to market.<\/p>\n

To that end, the company has struck a $2.75 billion deal,\u00a0announced Sunday (March 29), with Hong Kong-based Insilico Medicine.<\/p>\n

The companies say this collaboration will use Insilico\u2019s\u00a0artificial intelligence (AI) engine\u00a0to accelerate the \u201cdiscovery and development of novel therapeutics.\u201d The agreement gives Lilly exclusive license to develop, manufacture and market these drugs, with the companies teaming on a variety of research and development programs.<\/p>\n

\u201cBy deploying frontier AI technologies that scale from biomarkers to life models, world models of human and animal life, we can identify multi-purpose targets driving multiple diseases at the same time,\u201d\u00a0Alex Zhavoronkov, founder and CEO of Insilico, said in a news release.<\/p>\n

\u201cWorking with Lilly, we aim to deliver transformative therapies that treat diseases with high unmet need. This collaboration is a testament to the power of AI in tackling the most complex challenges in human health.\u201d<\/p>\n

Speaking\u00a0to CNBC about the partnership, Zhavoronkov said his company has used AI to develop at least 28 drugs, close to half of which are already at a clinical stage.<\/p>\n

We\u2019d love to be your preferred source for news.<\/p>\n

Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!<\/p>\n

Advertisement: Scroll to Continue<\/p>\n

\u201cIn many ways, Lilly is better than us in some areas of AI,\u201d he said, adding the pharmaceutical company has \u201cone person\u201d who has combined biology, chemistry and automation under one roof.<\/p>\n

The partnership is the latest example of how the\u00a0pharmaceutical sector\u00a0is \u201cmoving from AI experiments to real operating use cases,\u201d as PYMNTS wrote recently.<\/p>\n

In addition to its agreement with Insilico, Eli Lilly has also, with\u00a0Nvidia, committed $1 billion over five years to finance \u201cthe talent, infrastructure and computing needed to tackle…<\/p>\n

Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Eli Lilly Makes $2.75 Billion Bet on AI-Powered Drug Discovery https:\/\/www.pymnts.com\/artificial-intelligence-2\/2026\/eli-lilly-makes-2-75-billion-bet-on-ai-powered-drug-discovery\/ Publish Date: 2026-03-30 08:24:00…<\/p>\n","protected":false},"author":1,"featured_media":229172,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.pymnts.com\/wp-content\/uploads\/2026\/03\/Eli-Lilly-AI-drug.png","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[],"class_list":["post-229171","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/229171"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=229171"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/229171\/revisions"}],"predecessor-version":[{"id":229173,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/229171\/revisions\/229173"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/229172"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=229171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=229171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=229171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}